Clinical Trial Update: Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether surgery can be omitted in clinically low-risk HER2-positive breast cancer patients who achieve complete response after standard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fundacio Clinic Barcelona | Conditions: HER2-positive Breast Cancer, Stage I Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-01-06